Delivery Order SPE2DB22D1002-SPE2DB24FKYW5

Award Date 3/5/24
Potential Completion Date 3/6/24
Potential Value $5.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of COSENTYX UNOREADY 300 MG PEN 2ML pharmaceuticals. The award, valued at $15,219.50, has a completion date of May 1, 2024 and does not utilize any set-aside designations. AmerisourceBergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31,...
The U.S. Defense Logistics Agency (DLA) awarded a $6,087.80 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, which is a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of COSENTYX UNOREADY 300 MG PEN 2ML pharmaceutical products. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025....
The Defense Logistics Agency (DLA) Troop Support Medical has awarded a $1,521.95 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, for the supply of COSENTYX SENSOREADY 150 MG PEN medication. This delivery order has a completion date of February 21, 2024. Amerisourcebergen Drug Corp is the prime contractor and has previously been awarded an indefinite delivery contract (IDC) by DLA with a potential value of $999,999,999.00 and a...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide COSENTYX SENSOREADY 150 MG PENML, a pharmaceutical product. The delivery order has a potential value of $10,695.50 and a completion date of March 1, 2024. Amerisourcebergen Drug Corp is the prime contractor and is not subject to any set-aside requirements. This delivery order is issued under a larger indefinite delivery contract...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit organization and subsidiary of Amerisourcebergen Corporation, to provide COSENTYX SNRDY 300MG DOSE-2PENML pharmaceutical products. The delivery order, valued at $2,310.95, has an ultimate completion date of April 3, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31,...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of COSENTYX SNRDY 300MG DOSE-2PENML pharmaceutical products. The contract has a potential value of $8,675.27 and a completion date of February 20, 2024. Amerisourcebergen Drug Corp is the prime contractor, and no set-aside designation was used for this award. This delivery order is issued under Amerisourcebergen's...
The Defense Logistics Agency (DLA) awarded a $7,660.53 firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of COSENTYX SNRDY 300MG DOSE-2PENML pharmaceutical products. This delivery order falls under a $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, which serves as the primary contract vehicle for the company to provide pharmaceutical products and medical supplies to DLA...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of COSENTYX SENSOREADY 150 MG PENML. The $8,952.58 delivery order has a completion date of March 1, 2024 and was awarded on February 29, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price Delivery Order contract worth $5,146.39 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the provision of COSENTYX SNRDY 300MG DOSE-2PENML, a pharmaceutical product, with a period of performance through January 26, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a Delivery Order contract valued at $102,235.72 to the Amerisourcebergen Drug Corp, Corporate Office division, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of the pharmaceutical product COSENTYX 300 MG DOSE-2 PENSML. This Delivery Order contract is placed under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999.00 through...
  • SPE2DB22D1002
    Indefinite Delivery Contract
  • SPE2DB22D1002-SPE2DB24FKYW5
    Delivery Order

The Defense Logistics Agency (DLA) awarded a $5,940.96 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide COSENTYX UNOREADY 300 MG PEN 2ML pharmaceutical products. The delivery order has a completion date of March 6, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp serves as a prime contractor for DLA Troop Support Medical, providing a wide range of pharmaceutical and medical supplies to support military treatment programs and facilities. This delivery order is issued under Amerisourcebergen Drug Corp's indefinite delivery contract (IDC) with DLA, which has a potential value of $999,999,999.00 and a performance period through December 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceuticals and medical materials to DLA Troop Support Medical on a firm fixed-price basis.

Generated 6/4/24, 9:48 AM